Axsome Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. 

CEO
Herriott Tabuteau
CEOHerriott Tabuteau
Employees
545
Employees545
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2012
Founded2012
Employees
545
Employees545

AXSM Key Statistics

Market cap
3.51B
Market cap3.51B
Price-Earnings ratio
-14.40
Price-Earnings ratio-14.40
Dividend yield
Dividend yield
Average volume
563.26K
Average volume563.26K
High today
$75.01
High today$75.01
Low today
$73.52
Low today$73.52
Open price
$75.01
Open price$75.01
Volume
390.88K
Volume390.88K
52 Week high
$98.40
52 Week high$98.40
52 Week low
$55.02
52 Week low$55.02

AXSM News

Seeking Alpha 3d
Axsome Therapeutics stock rises on upgrade to Overweight at Morgan Stanley

Axsome Therapeutics (NASDAQ:AXSM) has been upgraded to Overweight from Equal-weight by Morgan Stanley banking on positive expected results from a late-stage stu...

Axsome Therapeutics stock rises on upgrade to Overweight at Morgan Stanley

Analyst ratings

94%

of 16 ratings
Buy
93.8%
Hold
6.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.